SCHEMBL17739621

SCHEMBL17739621

CC1(C)c2ccccc2N(c2nc(-c3ccccc3)nc(N3c4ccccc4C(C)(C)c4ccccc43)n2)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ LMNA P02545 5/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ HTT P42858 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ PAX8 Q06710 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15490803 0.97 L3MBTL1 (0.44) L3MBTL1LMNAKMT2AMEN1NPSR1
SCHEMBL13231535 0.89 KMT2A (0.42) LMNAKMT2AMEN1NPSR1HTT
SCHEMBL12435727 0.85 L3MBTL1 (0.35) L3MBTL1LMNAKMT2AMEN1TDP1
SCHEMBL15084753 0.85 NR1H2 (0.36) L3MBTL1LMNAKMT2AMEN1NPSR1
SCHEMBL18624231 0.84 L3MBTL1 (0.40) L3MBTL1LMNAKMT2AMEN1NPSR1
SCHEMBL18624228 0.84 L3MBTL1 (0.40) L3MBTL1LMNAKMT2AMEN1NPSR1
SCHEMBL28970644 0.84 L3MBTL1 (0.37) L3MBTL1LMNAKMT2AMEN1NPSR1
SCHEMBL17278546 0.84 L3MBTL1 (0.42) L3MBTL1LMNAKMT2AMEN1NPC1
SCHEMBL17278591 0.84 L3MBTL1 (0.42) L3MBTL1LMNAKMT2AMEN1NPC1
SCHEMBL29397786 0.84 L3MBTL1 (0.42) L3MBTL1LMNAKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10651399-B2 Delayed fluorescence compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2020-05-12 — — US disclosed
US-20190036035-A1 Delayed Fluorescence Compound, and Organic Light Emitting Diode and Display Device Using the Same LG DISPLAY CO., LTD. (KR) 2019-01-31 — — US disclosed
US-10193085-B2 Delayed fluorescence compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2019-01-29 — — US disclosed
US-20180205023-A1 Delayed Fluorescence Compound, and Organic Light Emitting Diode and Display Device Using the Same LG DISPLAY CO., LTD. (KR) 2018-07-19 — — US disclosed
US-20180205023-A1 Delayed Fluorescence Compound, and Organic Light Emitting Diode and Display Device Using the Same LG DISPLAY CO., LTD. (KR) 2018-07-19 — — US disclosed
EP-3020783-B1 DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO LTD (KR) 2018-06-06 — — EP disclosed
US-9954186-B2 Delayed fluorescence compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2018-04-24 — — US disclosed
US-9954186-B2 Delayed fluorescence compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2018-04-24 — — US disclosed
EP-3020783-A1 DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG Display Co., Ltd. (KR) 2016-05-18 — — EP disclosed
US-20160133856-A1 DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-05-12 — — US disclosed
US-20160133856-A1 DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10193085-B2 Delayed fluorescence compound, and organic light emitting diode and display device using the same OCIAD1, OCIAD2, OGFOD1 L3MBTL1 363/4885LMNA 4362/4885KMT2A 2194/4885
US-10651399-B2 Delayed fluorescence compound, and organic light emitting diode and display device using the same OCIAD1, OCIAD2, DRD2 L3MBTL1 165/4885LMNA 3946/4885KMT2A 1932/4885
US-20190036035-A1 Delayed Fluorescence Compound, and Organic Light Emitting Diode and Display Device Using the Same OCIAD1, OCIAD2, DRD2 L3MBTL1 165/4885LMNA 3946/4885KMT2A 1932/4885
US-20160133856-A1 DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME OCIAD1, OCIAD2, OGFOD1 L3MBTL1 363/4885LMNA 4362/4885KMT2A 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback